Pursuant to the Regulation 30 read with Part A of Schedule III of the Securities Exchange Board of India (Listing Obligations and Disclosure Requirements) Regulations, 2015, request you ....
Price
▲ positive · ▼ negative · ● neutral filings · teal = economic event · numbered = multiple that day (click to pick). Times IST.
Awaiting price reaction for this filing.
Microse India Limited's board, at its meeting on 10 November 2025, approved the unaudited financial results for the quarter and half year ended 30 September 2025, which have been subjected to a limited review by the statutory auditor (Todarwal & Todarwal LLP) with no qualifications noted. For Q2 FY26 (quarter ended 30 Sep 2025), revenue from operations was negative at Rs. (1.55) lakhs, and the company posted a loss before tax of Rs. (8.86) lakhs. For H1 FY26 (six months ended 30 Sep 2025), total revenue stood at Rs. (103.03) lakhs, with a sharply wider loss before tax of Rs. (157.00) lakhs versus Rs. (10.27) lakhs in the same period last year. Reserves and surplus are deeply negative at Rs. (147.94) lakhs, while short-term borrowings rose to Rs. 87.81 lakhs (from Rs. 60.01 lakhs a year ago) and cash remains negligible at Rs. 0.95 lakhs. The negative revenue reflects write-downs/change in inventory of delisted stock rather than ongoing sales activity, and the company operates in a single business segment.
The results are materially weak — losses have widened more than 15x YoY for H1 FY26 and the balance sheet shows eroded reserves, rising short-term debt and almost no cash, signalling serious financial stress that could weigh on the stock and raise going-concern concerns for shareholders. Investors should treat this as a high-risk, small-cap situation pending clarity on the company's revival plans.